Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
European Journal of Endocrinology|April 29, 2024
Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetesCoco M Fuhri Snethlage, Abraham S Meijnikman, Anne Linde Mak, et al.
Gastroenterology|August 9, 2005
Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantationLee H Bouwman, Anja Roos, Onno T Terpstra, et al.
Blood|August 31, 2022
A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host diseaseAstrid G S van Halteren, Jessica S Suwandi, Sander Tuit, et al.
Transplantation|August 22, 2018
Islet Allotransplantation in the Bone Marrow of Patients With Type 1 Diabetes: A Pilot Randomized TrialPaola Maffi, Rita Nano, Paolo Monti, et al.
Diabetologia|April 20, 2018
Abnormal islet sphingolipid metabolism in type 1 diabetesLaurits J Holm, Lars Krogvold, Jane P Hasselby, et al.
Plos One|November 17, 2012
Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null miceWendy W J Unger, Todd Pearson, Joana R F Abreu, et al.
Diabetologia|March 8, 2023
Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cellsRené van Tienhoven, Maria J L Kracht, Arno R van der Slik, et al.
Diabetes|July 16, 2009
Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patientsRobert Hilbrands, Volkert A L Huurman, Pieter Gillard, et al.
American Journal of Human Genetics|November 14, 2007
Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseasesAlexandra Zhernakova, Behrooz Z Alizadeh, Marianna Bevova, et al.
Science Translational Medicine|June 28, 2013
Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8⁺ T cells in type 1 diabetesBart O Roep, Nanette Solvason, Peter A Gottlieb, et al.
Pageof 18